Our research

Cancer

Cancer is a significant global health issue and a leading cause of death worldwide. Our specialists are exploring a wide range of treatments, tackling challenges such as drug resistance, and advancing diagnostic technologies for various cancers including breast, ovarian, prostate, lymphoma, melanoma, sarcoma, brain tumours and rare cancers. Our research and key clinical collaborators place us at the cutting edge of cancer glycomics, a field that examines the interactions between sugar molecules and proteins on the surface of cancer cells. Our researchers are leveraging this innovative approach to discover new solutions for cancer diagnosis and treatment.

Infectious diseases

Infectious diseases represent some of the most significant health challenges globally, claiming millions of lives each year. There is an urgent need to develop new strategies to combat diseases caused by bacterial, viral, parasitic and fungal pathogens. The rising threat of antibiotic resistance further exacerbates this global concern. Our experts are committed to discovering innovative approaches to address antibiotic resistance and the shortage of effective vaccines for some of the world’s most serious viral and bacterial pathogens.

Neurological conditions

Neurological conditions are characterised by the progressive degeneration of the structure and function of the central and peripheral nervous systems, leading to issues with movement and mental function. As the global population ages, the number of people affected by these conditions is expected to rise. Our experts are addressing conditions such as spinal injury, neurodegeneration, peripheral nerve repair, axon degeneration, Parkinson’s disease, mental health, PTSD and pain. Their goal is to deliver solutions that significantly improve the quality of life for individuals with diseases and injuries of the nervous system.

Find out more